AzTrials
AzTrials

Muscle AtrophyNCT06962683

Post-surgery Muscle Preservation and Pain Reduction Through Blood Flow Restriction Training in Orthopedic Spinal Surgery

A study testing Blood-Flow-Restriction Training in people with Muscle Atrophy and Postoperative Pain, run by University Hospital, Bonn at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This project investigates the effects of the Blood-Flow-Restriction (BFR) training method on postoperative muscle atrophy and pain after spinal surgery. Two groups are formed for this purpose. Read more about this study

Who is it for?
Ages 18 to 100 years
What is being tested?
Blood-Flow-Restriction Training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
1 siteGermany
Study dates
1 Mar 2022to 1 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The study includes all patients with a medical indication for spinal surgical therapy (including herniated disc, vertebral fracture, spinal stenosis, spondylodiscitis, etc).
  • All participating patients have given their written informed consent to participate in the study.
  • Patients aged between 18-85 years will be included.

Who cannot join

  • Acute or chronic infections of the extremities.
  • Pregnancy and lactation
  • Inability to undergo surgery

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University Hospital Bonn

    Bonn, North Rhine-Westphalia, 53127

Other trials in Germany

About this study

Official title: Post-surgery Muscle Preservation Through Blood Flow Restriction Training in Orthopedic Spinal Surgery

This project investigates the effects of the Blood-Flow-Restriction (BFR) training method on postoperative muscle atrophy and pain after spinal surgery. Two groups are formed for this purpose. The intervention group receives a everyday BFR training during the postoperative stay at an individually measured occlusion pressure of 60-80%. The control group performs sham-BFR training at a fixed occlusion pressure of 20mmHg. The examinations are carried out before and several times after the operation (longest follow-up: 6 months). Among other things, muscle mass, muscle strength, pain perception and quality of life are assessed using questionnaires.

Read the detailed description

Methodology and implementation Type of study

Prospective, interventional study in the context of clinical orthopedic routine (Non-AMG, Non-MPG):

This scientific project investigates the influence of blood-flow restriction training as a therapeutic intervention after spinal surgery for postoperative muscle preservation.

Study design Parallel study design The aim of this study is to investigate the influence of postoperative blood-flow restriction (BFR) application on muscle preservation and muscular-functional rehabilitation after spinal surgery. Postoperative muscle mass and strength loss is related not only to the size of the surgical procedure, but also to the prolonged rehabilitation after spine surgery. Since our patients are not able to perform large mechanical loads for a longer period of time (usually six weeks), we use the BFR training method as a training intervention.

The thesis of this work focuses the postoperative use of BFR training to reduce muscle atrophy during hospitalisation phase, and the supporting effects of BFR-Training on functional rehabilitation. For this purpose, a partially blinded randomised controlled trial will treat one group with BFR and one group with Sham-BFR and compare the results.

Classification of patients and study procedure Subjects who fulfil the above-mentioned inclusion criteria for study participation will be informed orally and by means of an information sheet about the planned study by the investigator and given written information.

Prior to the start of the study, the written consent of the subjects to participate in the study will be obtained. The study takes into account the ethical principles of the Declaration of Helsinki in its current version (2013).

Randomisation of patients The patients will be divided into two groups of 25 patients each. Randomisation will be done by classical analogue double lottery.

  1. Control (CG) The first group will serve as the control group and will receive an additional daily Sham BFR intervention of 20mmHg postoperatively as part of routine clinical care.
  2. BFR intervention (BFR) The second group serves as the intervention group and receives an additional daily BFR intervention of 60-80% of the individual arterial occlusion pressure postoperatively as part of routine clinical care.

Description of the interventions Intervention: Blood-Flow Restriction Training (BFR). BFR training involves the application of tourniquets during a passive or active movement intervention to provide an additive metabolic stimulus. The tourniquets are applied as far as possible proximally to the thigh and a pressure is applied during the movement that suppresses only part of the venous return of an extremity (=venous pooling). Venous occlusion is induced by a cuff system routinely used in strength training (Delfi Medical Innovations Inc., Vancouver, Canada). The pressure applied is calculated on the basis of the individual occlusion pressure via duplex sonography at the start of each training session. The test person lies at rest while the cuff is inflated until no more blood flow can be detected in the extremity (= occlusion pressure). Of this occlusion pressure, 60-80% is subsequently used for the BFR intervention. The loading protocol provides for daily units of 60 minutes at intervals (5 minutes occlusion + 5 minutes free flow, six times in total), over a period of two to 14 days.

Control: Control group, Sham-BFR (CG). Patients in the control group (CG) perform the same exercise protocol as patients in the BFR intervention group, except that they receive the standardized low BFR pressure of 20mmHg.

Investigation/aim parameters of the study Investigations For the purpose of this project, the examinations will be divided into basal examinations and in-rehabilitation examinations.

  1. Basal examinations All participating patients will undergo a multi-layered battery of tests before and after surgery, as well as long-term post-operative follow-up at 3, 6 and 12 months. The basal examinations take place on the premises of the orthopaedic clinic of the University Hospital Bonn. Examinations include measurement of muscle mass, muscle strength, pain perception and subjective questionnaires.
  2. In-rehabilitation monitoring Vital signs such as blood pressure, pulse, oxygen saturation are taken before and after exercise with BFR, and a capillary blood sample is taken to show venous blood gases.

Study population

Patient inclusion criteria:

  • The study includes all patients with a medical indication for spinal surgical therapy (including herniated disc, vertebral fracture, spinal stenosis, spondylodiscitis, etc).
  • All participating patients have given their written informed consent to participate in the study.
  • Patients aged between 18-85 years will be included.

Patient exclusion criteria:

  • Acute or chronic infections of the extremities.
  • Pregnancy and lactation
  • Inability to undergo surgery

Number of patients: 30 (two groups with 15 subjects each)

Discontinuation of the study in one patient (drop-out)

One or more of the following circumstances may lead to a patient dropping out of the study (this patient will be counted as a drop-out):

  • Withdrawal of the patient's consent without giving a reason.
  • Occurrence of an exclusion criterion
  • Violation of the study protocol
  • Participation in < 80% of the intervention sessions

Statistical calculation of the number of cases A power analysis performed using G*Power 3.1.9. assuming a mean effect size (f) of 0.25, an alpha error of 0.05 and a test power of (1-β) of 0.85 for the analysis of variance with repeated measures resulted in an optimal sample size of N = 26 (i.e. 13 subjects per group).

Because of the long follow-up period of 6 months and the resulting increased possibility of drop-out patients, we agreed on a number of 25 subjects per group.

Recruitment measures The patients will be recruited from the patient pool of the Department of Orthopaedics and Trauma Surgery of the University Hospital Bonn.

Archiving and data protection All data generated in the course of the study are protected by data protection laws. Personal data will not be passed on or made accessible to the public by the medically responsible study director or the investigator (Alexander Franz) or any other person involved in the conduct of the study. Only pseudonymized patient data will be passed on and stored. The pseudonymization is carried out by means of an ascending numerical series by the medically responsible study director or the investigator. Only the investigators are allowed to assign the personal data to the study data. The allocation key is stored on an external hard drive and is managed by the principal investigator (Alexander Franz). After completion of the study, the allocation key is deleted and the data management is changed from pseudonymization to anonymization. The evaluation of the data will be anonymized. All data will be managed in accordance with data protection regulations.

Being tested
Blood-Flow-Restriction Training, Sham-BFR
Medical subject headings
Muscular Atrophy, Pain, Postoperative, Spondylolisthesis, Discitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood-Flow-Restriction TrainingOther

    Also called BFR

    For the pBFR intervention, the Personalized Tourniquet System for Blood Flow Restriction from Delfi Medical Innovations Inc. (Vancouver, Canada) were used. The cuffs were applied to both lower extremities as far proximally as possible and were connected to the control device. Before starting the training program, the individual LOP was measured of both lower limb in a restring, laying position by the control device. The Intervention-Group performed the training at 80% of their individual LOP. The training was performed alternately on both lower extremities. The time intervals were set at five minutes occlusion and five minutes rest. Each leg received five intervals of BFR-induced occlusion training, resulting in a total 50 minutes of daily training. During the entire training period, the patient was in a resting position, laying in the hospital bed.

  • Sham-BFROther

    For the sham-BFR intervention, the Personalized Tourniquet System for Blood Flow Restriction from Delfi Medical Innovations Inc. (Vancouver, Canada) were used. The cuffs were applied to both lower extremities as far proximally as possible and were connected to the control device. Before starting the training program, the individual LOP was measured of both lower limb in a restring, laying position by the control device. The Control-Group was trained with a fixed pressure of 20 mmHg, independent of their individual LOP. The training was performed alternately on both lower extremities. The time intervals were set at five minutes occlusion and five minutes rest. Each leg received five intervals of BFR-induced occlusion training, resulting in a total 50 minutes of daily training. During the entire training period, the patient was in a resting position, laying in the hospital bed.

Study groups in NCT06962683
Study groupRoleWhat they receive
Control GroupSham comparatorThe first group will serve as the control group and will receive an additional daily Sham BFR intervention of 20mmHg postoperatively as part of routine clinical care.
Receives: Other: Sham-BFR
Intervention GroupExperimentalThe second group will serve as the intervention group and will receive an additional daily passiveBFR intervention with 80% of the individual LOP postoperatively as part of routine clinical care.
Receives: Other: Blood-Flow-Restriction Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle Mass

    BIA-/ DXA-Measurement

    Measured: Pre- to 6 weeks Post Surgery

Secondary outcomes (1)
  1. Perceived Pain

    VAS 100mm

    Measured: Pre- to 6 weeks Post Surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2025
  2. Study start1 Mar 2022
  3. Primary completion1 Nov 2024
  4. Study completion1 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06962683
Sponsor's protocol ID
UBonn_WBS_BFR
Status last verified
Apr 2025
First submitted
15 Apr 2025
Last updated
16 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Blood-Flow-Restriction Training in people with Muscle Atrophy and Postoperative Pain, run by University Hospital, Bonn at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle Mass (time frame: Pre- to 6 weeks Post Surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in